ONLINE DATABASE SEARCH - HIV-LS-301-MEMO
1. 43757 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Use of b defensin or its inducing agents for treating HIV-1 associated with chemokine receptor CXCR4 (Case Western Reserve University, USA)
Weinberg, Aaron
PATENT: WO 2004054603 A2; ISSUE DATE: 20040701
APPLICATION: 2003; PP: 63 pp.
2. 43758 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Nido-carborane-containing porphyrin compounds for the treatment and prevention of viral infections ((USA))
Vicente, Maria Da Graca Henriques and Marzilli, Luigi G
PATENT: US 2004116385 A1; ISSUE DATE: 20040617
APPLICATION: 2003-56868; PP: 22 pp.
3. 43759 HIV-LS-301; PUBMED-HIV-7/26/2004
Anti-AIDS Agents. 60. Substituted 3'R,4'R-Di-O-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) Analogues as Potent Anti-HIV Agents
Yu, D, Chen, CH, Brossi, A, and Lee, KH
J Med Chem 2004. 47(16): 4072-82
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15267246&dopt=abstract
4. 43760 HIV-LS-301; PUBMED-HIV-7/26/2004
Clinical utility of current NNRTIs and perspectives of new agents in this class under development
Zhang, Z, Hamatake, R, and Hong, Z
Antivir Chem Chemother 2004. 15(3): 121-34
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15266894&dopt=abstract
5. 43761 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Modulation of HIV replication by RNA interference((University of Massachusetts, USA)
Stevenson, Mario and Jacque, Jean-Marc
PATENT: WO 2004047764 A2; ISSUE DATE: 20040610
APPLICATION: 2003; PP: 59 pp.
6. 43762 HIV-LS-301; PUBMED-HIV-7/26/2004
In Vitro Interaction of the HIV Protease Inhibitor Ritonavir with Herbal Constituents: Changes in P-gp and CYP3A4 Activity
Patel, J, Buddha, B, Dey, S, Pal, D, and Mitra, AK
Am J Ther 2004. 11(4): 262-277
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15266218&dopt=abstract
7. 43763 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Substituted N-phenylpyrrole compounds for inhibition of HIV infection by blocking HIV entry((New York Blood Center, USA)
Jiang, Shibo and Debnath, Asim Kumar
PATENT: WO 2004047730 A2; ISSUE DATE: 20040610
APPLICATION: 2003; PP: 61 pp.
8. 43764 HIV-LS-301; PUBMED-HIV-7/26/2004
Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors
Aiello, F, Brizzi, A, Garofalo, A, Grande, F, Ragno, G, Dayam, R, and Neamati, N
Bioorg Med Chem 2004. 12(16): 4459-66
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15265496&dopt=abstract
9. 43765 HIV-LS-301; SCIFINDER-HIV-7/21/2004
a-Glucosidase inhibitors from a natural source, and therapeutic use((Council of Scientific and Industrial Research, India)
Rao, Janaswamy Madhusudana, Srinivas, Pullela Venkata, Anuradha, Vummenthala, Tiwari, Ashok Kumar, Ali, Amtul Zehra, Yadav, Jhillu Singh, and Raghavan, Kondapura Vijaya
PATENT: WO 2004041295 A1; ISSUE DATE: 20040521
APPLICATION: 2002; PP: 28 pp.
10. 43766 HIV-LS-301; PUBMED-HIV-7/26/2004
Synthetic Bivalent CD4-Mimetic Miniproteins Show Enhanced Anti-HIV Activity over the Monovalent Miniprotein
Li, H, Song, H, Heredia, A, Le, N, Redfield, R, Lewis, GK, and Wang, LX
Bioconjug Chem 2004. 15(4): 783-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15264865&dopt=abstract
11. 43767 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1
Balzarini, J
Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates) 2004. 4(9): 921-944
12. 43768 HIV-LS-301; PUBMED-HIV-7/26/2004
A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitors
Hwang, YS and Chmielewski, J
Bioorg Med Chem Lett 2004. 14(16): 4297-300
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15261290&dopt=abstract
13. 43769 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Aryl phosphate derivatives of d4T having activity against resistant HIV strains((USA))
Uckun, Fatih M
PATENT: US 2004087549 A1; ISSUE DATE: 20040506
APPLICATION: 2002-19189; PP: 31 pp.
14. 43770 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Methods for preventing HIV-1 or HIV-2 infection((New York Blood Center, Inc. USA)
Neurath, Alexander R, Jiang, Shibo, and Debnath, Asim Kumar
PATENT: US 6727240 B1; ISSUE DATE: 20040427
APPLICATION: 94-15065; PP: 11 pp., Cont.-in-part of U.S. Ser. No. 174,662.
15. 43771 HIV-LS-301; SCIFINDER-HIV-7/21/2004
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors
Billick, Erika, Seibert, Christoph, Pugach, Pavel, Ketas, Tom, Trkola, Alexandra, Endres, Michael J, Murgolo, Nicholas J, Coates, Elizabeth, Reyes, Gregory R, Baroudy, Bahige M, Sakmar, Thomas P, Moore, John P, and Kuhmann, Shawn E
Journal of Virology 2004. 78(8): 4134-4144
16. 43772 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Gp41 peptide derivative fusion inhibitors of HIV infection((USA))
Xie, Dong and Jiang, He
PATENT: WO 2004029201 A2; ISSUE DATE: 20040408
APPLICATION: 2003; PP: 51 pp.
17. 43773 HIV-LS-301; PUBMED-HIV-7/26/2004
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety
Seto, M, Aramaki, Y, Imoto, H, Aikawa, K, Oda, T, Kanzaki, N, Iizawa, Y, Baba, M, and Shiraishi, M
Chem Pharm Bull (Tokyo) 2004. 52(7): 818-29
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15256702&dopt=abstract
18. 43774 HIV-LS-301; PUBMED-HIV-7/26/2004
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A
Liu, S, Asparuhova, M, Brondani, V, Ziekau, I, Klimkait, T, and Schumperli, D
Nucleic Acids Res 2004. 32(12): 3752-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15254276&dopt=abstract
19. 43775 HIV-LS-301; PUBMED-HIV-7/26/2004
Prospects of HIV-1 entry inhibitors as novel therapeutics
Pierson, TC, Doms, RW, and Pohlmann, S
Rev Med Virol 2004. 14(4): 255-70
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15248253&dopt=abstract
20. 43776 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Novel inhibitors of HIV-1 integration
Witvrouw, M, Van Maele, B, Vercammen, J, Hantson, A, Engelborghs, Y, De Clercq, E, Pannecouque, C, and Debyser, Z
Current Drug Metabolism 2004. 5(4): 291-304
21. 43777 HIV-LS-301; PUBMED-HIV-7/26/2004
Recent insights into HIV-1 Vif
Navarro, F and Landau, NR
Curr Opin Immunol 2004. 16(4): 477-82
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15245742&dopt=abstract
22. 43778 HIV-LS-301; SCIFINDER-HIV-7/21/2004
New Phosphonoformic Acid Derivatives of 3'-Azido-3'-Deoxythymidine
Shirokova, EA, Jasko, MV, Khandazhinskaya, AL, Ivanov, AV, Yanvarev, DV, Skoblov, YuS, Pronyaeva, TR, Fedyuk, NV, Pokrovskii, AG, and Kukhanova, MK
Russian Journal of Bioorganic Chemistry (Translation of Bioorganicheskaya Khimiya) 2004. 30(3): 242-249
23. 43779 HIV-LS-301; SCIFINDER-HIV-7/21/2004
In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes
Naoko, Miyano-Kurosaki, Barnor, Jacob Samson, Takeuchi, Hiroaki, Owada, Takashi, Nakashima, Hideki, Yamamoto, Naoki, Matsuzaki, Tetsuo, Shimada, Fumiyuki, and Takaku, Hiroshi
Antiviral Chemistry & Chemotherapy 2004. 15(2): 93-100
24. 43780 HIV-LS-301; PUBMED-HIV-7/26/2004
Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites
Hotchkiss, G, Maijgren-Steffensson, C, and Ahrlund-Richter, L
Mol Ther 2004. 10(1): 172-80
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15233952&dopt=abstract
25. 43781 HIV-LS-301; PUBMED-HIV-7/26/2004
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development
Cooper, DA and Lange, JM
Lancet Infect Dis 2004. 4(7): 426-36
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15219553&dopt=abstract
26. 43782 HIV-LS-301; SCIFINDER-HIV-7/21/2004
HIV-1 gp41 as a target for viral entry inhibition
Root, Michael J and Steger, HKirby
Current Pharmaceutical Design 2004. 10(15): 1805-1825
27. 43783 HIV-LS-301; WOS-HIV-7/18/2004
N-linked glycosylation in the CXCR4 N-tenninus inhibits binding to HIV-1 envelope glycoproteins
Wang, JB, Babcock, GJ, Choe, H, Farzan, M, Sodroski, J, and Gabuzda, D
VIROLOGY 2004. 324(1): 140-150
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222140800014
28. 43784 HIV-LS-301; SCIFINDER-HIV-7/21/2004
A study on the anti-HIV activity of biflavonoid compounds by using quantum chemical and chemometric methods
Molfetta, FA, Honorio, KM, Alves, CN, and da Silva, ABF
THEOCHEM 2004. 674(1-3): 191-197
29. 43785 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (Etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
Das, Kalyan, Clark, Arthur D Jr, Lewi, Paul J, Heeres, Jan, De Jonge, Marc R, Koymans, Lucien MH, Vinkers, HMaarten, Daeyaert, Frederik, Ludovici, Donald W, Kukla, Michael J, De Corte, Bart, Kavash, Robert W, Ho, Chih Y, Ye, Hong, Lichtenstein, MarkA, Andries, Koen, Pauwels, Rudi, De Bethune, Marie-Pierre, Boyer, Paul L, Clark, Patrick, Hughes, Stephen H, Janssen, Paul AJ, and Arnold, Eddy
Journal of Medicinal Chemistry 2004. 47(10): 2550-2560
30. 43786 HIV-LS-301; SCIFINDER-HIV-7/21/2004
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future
De Clercq, Erik
Chemistry & Biodiversity 2004. 1(1): 44-64
31. 43787 HIV-LS-301; WOS-HIV-7/18/2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists
Urbinati, C, Bugatti, A, Oreste, P, Zoppetti, G, Waltenberger, J, Mitola, S, Ribatti, D, Presta, M, and Rusnati, M
FEBS LETT 2004. 568(1-3): 171-177
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222205200034
32. 43788 HIV-LS-301; WOS-HIV-7/18/2004
Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs
Seibert, C and Sakmar, TP
CURR PHARM DESIGN 2004. 10(17): 2041-2062
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222130200006
33. 43789 HIV-LS-301; WOS-HIV-7/18/2004
Highly active Antiretroviral therapy and viral response in HIV type 2 infection
Mullins, C, Eisen, G, Popper, S, Sarr, AD, Sankale, JL, Berger, JJ, Wright, SB, Chang, HR, Coste, G, Cooley, TP, Rice, P, Skolnik, PR, Sullivan, M, and Kanki, PJ
CLIN INFECT DIS 2004. 38(12): 1771-1779
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222087500021
34. 43790 HIV-LS-301; WOS-HIV-7/18/2004
Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes
Creery, D, Weiss, W, Lim, WT, Aziz, Z, Angel, JB, and Kumar, A
CLIN EXP IMMUNOL 2004. 137(1): 156-165
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222050100022
35. 43791 HIV-LS-301; WOS-HIV-7/18/2004
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review
Jaffar, S, Grant, AD, Whitworth, J, Smith, PG, and Whittle, H
B WORLD HEALTH ORGAN 2004. 82(6): 462-469
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222126900012
36. 43792 HIV-LS-301; WOS-HIV-7/25/2004
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
Darfeuille, F, Hansen, JB, Orum, H, Primo, CD, and Toulme, JJ
NUCLEIC ACIDS RES 2004. 32(10): 3101-3107
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222118600022
37. 43793 HIV-LS-301; WOS-HIV-7/25/2004
Regulation of CXCR4 receptor dimerization by the chemokine SDF-1 alpha and the HIV-1 coat protein gp120: A fluorescence resonance energy transfer (FRET) study
Toth, PT, Ren, DJ, and Miller, RJ
J PHARMACOL EXP THER 2004. 310(1): 8-17
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222138300002
38. 43794 HIV-LS-301; WOS-HIV-7/25/2004
Isolation and structure of antagonists of chemokine receptor (CCR5)
Jayasuriya, H, Herath, KB, Ondeyka, JG, Polishook, JD, Bills, GF, Dombrowski, AW, Springer, MS, Siciliano, S, Malkowitz, L, Sanchez, M, Guan, ZQ, Tiwari, S, Stevenson, DW, Borris, RP, and Singh, SB
J NAT PROD 2004. 67(6): 1036-1038
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222277100023
39. 43795 HIV-LS-301; WOS-HIV-7/25/2004
Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell leukemia virus type 1 protease
Kadas, J, Weber, IT, Bagossi, P, Miklossy, G, Boross, P, Oroszlan, S, and Tozser, J
J BIOL CHEM 2004. 279(26): 27148-27157
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222120400041
40. 43796 HIV-LS-301; WOS-HIV-7/25/2004
Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors
Domaoal, RA and Demeter, LM
INT J BIOCHEM CELL B 2004. 36(9): 1735-1751
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222255900007